SCHEMBL13879546

SCHEMBL13879546

Cc1cc(N2C(=O)NC(C)(Cc3ccccc3)C2=O)c(C(F)(F)F)o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 2/20 0.41
AR P10275 7/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
ELANE P08246 3/20 0.36
ITGB2 P05107 1/20 0.34
ICAM1 P05362 1/20 0.34
GAA P10253 1/20 0.33
OPRM1 P35372 1/20 0.33
ATM Q13315 1/20 0.33
RORC P51449 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
CTSG P08311 1/20 0.32
PRTN3 P24158 1/20 0.32
TSHR P16473 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11569756 0.72 ELANE (0.61) ITGALARELANEITGB2ICAM1
SCHEMBL13879517 0.72 ITGAL (0.51) ITGALELANEITGB2ICAM1ATM
SCHEMBL13879591 0.70 MGLL (0.47) ITGALELANEALDH1A1MAPTKMT2A
SCHEMBL13879533 0.70 ITGAL (0.76) ITGALARELANEITGB2ICAM1
SCHEMBL1514022 0.69 ITGAL (0.48) ITGALELANEITGB2ICAM1GAA
SCHEMBL12542988 0.69 ITGAL (0.48) ITGALELANEITGB2ICAM1GAA
SCHEMBL1514026 0.69 ITGAL (0.48) ITGALELANEITGB2ICAM1GAA
SCHEMBL13879551 0.68 ITGAL (0.62) ITGALARELANEITGB2ICAM1
SCHEMBL13879406 0.68 AR (0.44) ARL3MBTL1ELANEKDM4EALDH1A1
SCHEMBL13879534 0.68 TSHR (0.51) ITGALELANEGAAATMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. 2009-04-16 US disclosed
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099186-A1 INHIBITORS OF VIRAL REPLICATION EIF2AK2, HAVCR2, RTF2 ITGAL 4495/4885AR 4274/4885L3MBTL1 1550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.